ContextVision ABOSL:CONTX +6.97%81 EV-to-FCF is 36.17 as of Jun. 29, 2026, which is 11% above its 10-year median of 32.45. GuruFocus rates OSL:CONTX with a GF Score™ of 81/100 and a GF Value™ of kr5.13 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 406 Healthcare Providers & Services companies, ContextVision AB ranks worse than 79.06% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ContextVision AB's Enterprise Value is kr205.0 Mil.
ContextVision AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr5.7 Mil. Therefore, ContextVision AB's EV-to-FCF for today is 36.17.
The historical rank and industry rank for ContextVision AB's EV-to-FCF or its related term are showing as below:
OSL:CONTX'
s EV-to-FCF Range Over the Past 10 Years
Min: -5594.19 Med: 32.45 Max: 710.94
Current: 36.17
During the past 13 years, the highest EV-to-FCF of ContextVision AB was 710.94. The lowest was -5594.19. And the median was 32.45.
OSL:CONTX's EV-to-FCF is ranked worse than 79.06% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.53
vs OSL:CONTX: 36.17
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ContextVision AB (OSL:CONTX) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ContextVision AB's PE Ratio (TTM) for today is calculated as:
ContextVision AB's share price for today is kr3.53.
ContextVision AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.064.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
ContextVision AB EV-to-FCF Related Terms
ContextVision AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for ContextVision AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:CONTX vs VEEV, BTSG, TEM: EV-to-FCF Comparison
For the Health Information Services subindustry, ContextVision AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ContextVision AB EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ContextVision AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where ContextVision AB's EV-to-FCF falls into.
ContextVision AB's current Enterprise Value is kr205.0 Mil.
ContextVision AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr5.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ContextVision AB (OSL:CONTX) has a EV-to-FCF of 36.17 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ContextVision AB and its competitors. This is 11% above median its historical median of 32.45. According to the industry distribution chart, ContextVision AB ranks #321 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 79.1%.
Is ContextVision AB's EV-to-FCF too high?
ContextVision AB's current EV-to-FCF of 36.17 is 11% above median its 10-year median of 32.45. The Healthcare Providers & Services industry median EV-to-FCF is 17.53. ContextVision AB's value of 36.17 is 106.3% above this industry median. Based on the distribution chart, ContextVision AB ranks #321 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, ContextVision AB has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ContextVision AB's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ContextVision AB ranks #321 out of 406 companies for EV-to-FCF. This places ContextVision AB in the lower half of its industry. The industry median EV-to-FCF is 17.53. ContextVision AB's value of 36.17 is 106.3% above this benchmark. While the company's 10-year median is 32.45 vs. the industry median of 17.53, ContextVision AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.53, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ContextVision AB's current EV-to-FCF of 36.17 is 106.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ContextVision AB and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ContextVision AB's current EV-to-FCF is 36.17, which is 11% above median its own 10-year median of 32.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContextVision AB stock overvalued right now?
Based on GuruFocus' analysis, ContextVision AB (OSL:CONTX) is currently considered Significantly Undervalued. The stock's GF Value™ is kr5.13, compared to a current price of kr3.53 — trading 31.2% below its estimated fair value. The current EV-to-FCF is 36.17, which is 11% above median its 10-year median of 32.45 and 106.3% above the Healthcare Providers & Services industry median of 17.53. ContextVision AB's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For ContextVision AB (OSL:CONTX), the current EV-to-FCF is 36.17 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ContextVision AB (OSL:CONTX) Overvalued in 2026?
Based on GuruFocus' analysis, ContextVision AB stock appears to be undervalued.
The current stock price of kr3.53 is trading 31.2% below its estimated GF Value™ of kr5.13.
GuruFocus considers ContextVision AB to be Significantly Undervalued.
Key valuation signals for OSL:CONTX:
EV-to-FCF: 36.17 (11% above median its 10-year median of 32.45)
GF Value™: kr5.13 vs. price of kr3.53 (31.2% below fair value)
Industry Position: 106.3% above the Healthcare Providers & Services median (#321 of 406)
No single metric tells the full story. See the OSL:CONTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. Its geographical segments are Asia, Europe, and America.
81GF Score
Get the complete analysis for OSL:CONTX
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CONTX has been successfully added to your 
